S&P 500
(-0.41%) 5 460.48 points
Dow Jones
(-0.12%) 39 119 points
Nasdaq
(-0.71%) 17 733 points
Oil
(-0.34%) $81.46
Gas
(-3.13%) $2.60
Gold
(0.01%) $2 336.90
Silver
(0.61%) $29.44
Platinum
(0.28%) $1 009.00
USD/EUR
(-0.06%) $0.933
USD/NOK
(0.45%) $10.68
USD/GBP
(-0.04%) $0.791
USD/RUB
(0.86%) $85.73

Realtime updates for FSD Pharma Inc [HUGE]

Exchange: NASDAQ Sector: Healthcare Industry: Drug Manufacturersā€”Specialty & Generic

Live Chart Being Loaded With Signals

Commentary ():
Our systems believe the stock currently is overvalued by -0.03% compare to its pairs and should correct downwards.

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease...

Stats
Today's Volume 0
Average Volume 0
Market Cap 0
EPS $-0.0431 ( Q4 | 2024-04-02 )
Next earnings date ( $-0.0600 ) 2024-07-18
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 0
(Sector) 42.63
(Industry) 0
ATR14 $0.0370 (22.84%)
ACOR -24.02%
ACRX 7.50%
ADMP 0.85%
ADMS 0.00%
AGRX -1.40%
AKAN -3.75%
ALIM 0.54%
AMPH -0.87%
AMYT 0.00%
ANIP 0.94%
AQST 0.39%
ASRT -5.34%
ATNX 0.00%
AVDL -1.75%
AYTU 0.00%
BFRI -2.39%
BGXX -34.22%
CLVR -2.22%
COLL -0.74%
CPIX 0.66%
CRDL 1.00%
CRON -0.43%
CYTH 5.83%
DCPH 0.00%
DERM 9.73%
DRRX -5.49%
DVAX -1.23%
EGRX 11.55%
EMBC 0.32%
EMBCV -9.33%
EOLS -0.73%
ESPR -3.90%
EVOK 5.48%
FLGC 6.71%
FLXN 0.00%
GHSI -0.35%
HCM -1.83%
HROW -0.52%
HUGE -4.71%
IMCC 2.20%
INCR 2.03%
IRWD 5.16%
ITCI -3.51%
IXHL 10.53%
JUPW 11.76%
KALA 9.92%
KIN 0.11%
KMDA -1.78%
LNTH -1.25%
NBIX 2.50%
NEPT 0.00%
NLTX 1.45%
OGI -3.75%
OPTN -3.70%
ORGO 6.06%
PAHC -2.50%
PCRX 2.51%
PETQ -0.45%
PLXP 0.00%
PPD 0.00%
PROC -0.40%
PRPH -2.11%
PTPI 2.69%
RDHL -2.58%
RDUS 4.30%
REPH -0.48%
RGC -5.88%
RMTI 0.00%
SCTL 0.92%
SCYX -1.48%
SIGA 3.13%
SISI -13.33%
SNDL -1.04%
SNOA 1.05%
SSIC 1.03%
SUPN -0.45%
SXTC -2.24%
THTX 0.00%
TKNO -1.44%
TLGT -13.85%
TLRY -4.05%
TXMD -7.47%
TYHT -3.90%
UPC -1.97%
VTRS 1.43%
ZYNE 2.36%
Correlation (AI algo v.1.1b): Overvalued: -0.03% $0.162 paired level. (The Algo Track The Changes Of The Most Correlated Stocks In Realtime And Give An Instant Update)

Volume Correlation

Long: -0.23 (neutral)
Short: -0.70 (moderate negative)
Signal:(24.268) Neutral

FSD Pharma Inc Correlation

10 Most Positive Correlations
APDN0.961
APVO0.957
SHLS0.956
ALLR0.952
GLPG0.951
ALGT0.949
MBIO0.945
LGHL0.942
JACK0.942
IART0.94
10 Most Negative Correlations
AEYE-0.952
VCTR-0.949
IVCB-0.944
SMTC-0.941
NKTR-0.939
VITL-0.937
GDST-0.937
GGAL-0.936
USAP-0.929
JAN-0.927

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

FSD Pharma Inc Correlation - Currency/Commodity

The country flag 0.80
( strong )
The country flag -0.52
( weak negative )
The country flag 0.00
( neutral )
The country flag 0.11
( neutral )
The country flag 0.61
( weak )
The country flag -0.66
( moderate negative )

FSD Pharma Inc Financials

Annual 2023
Revenue: $0
Gross Profit: $-2.55M (0.00 %)
EPS: $-0.470
FY 2023
Revenue: $0
Gross Profit: $-2.55M (0.00 %)
EPS: $-0.470
FY 2022
Revenue: $0
Gross Profit: $-4.36M (0.00 %)
EPS: $-0.600
FY 2021
Revenue: $0.00
Gross Profit: $0.00 (0.00 %)
EPS: $-1.010

Financial Reports:

No articles found.

FSD Pharma Inc Options Data

Calls

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

Puts

Contract Name Last Trade Date (EDT) Strike Last Price Bid Ask Change % Change Volume Open Interest Implied Volatility Strike Date
No data available

FSD Pharma Inc

FSD Pharma Inc., through its subsidiaries, operates as a pharmaceutical research and development company. Its lead candidate includes FSD-201 that is in the Phase II clinical trial to treat COVID-19 disease. The company also focuses on Lucid-PSYCH, a psychoactive molecule identified for the potential treatment of neuropsychiatric disorders, such as depressive disorder; and Lucid-MS, a patented new chemical entity shown to prevent and reverse myelin degradation, the underlying mechanism of multiple sclerosis, in preclinical models. FSD Pharma Inc. was founded in 1998 and is headquartered in Toronto, Canada.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators

Total Execution Time: 2.2751729488373 seconds
Number of API calls: 3
Number of DB calls: 9